RobertPaulHasserjianMD

PubMed

• Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study.
  Genevieve M Crane, Julia T Geyer, Beenu Thakral, Sa A Wang, Geoffrey D Wool, Ke David Li, Adam R Davis, Leonardo Boiocchi, David Bosler, Carlos E Bueso-Ramos, Daniel A...> ;American Journal of Clinical Pathology. 2024 Apr 10
• Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
  Sarro, R., Bisig, B., Guey, B., Missiaglia, E., Cairoli, A., Omoumi, P., Letovanec, I., de Leval, L., Ferry, J., Hasserjian, R.> ;Modern Pathology. 2024 Jan 28
• Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
  Sam Sadigh, Daniel J DeAngelo, Jacqueline S Garcia, Robert P Hasserjian, Christopher B Hergott, Andrew A Lane, Scott B Lovitch, Fabienne Lucas, Marlise R Luskin, Eliza...> ;Modern Pathology. 2024 Jan 1
• Morphologic Characteristics of Myelodysplastic Syndromes.
  Lisa D Yuen, Robert P Hasserjian> ;Clinics in Laboratory Medicine. 2023 Dec 1
• 2 citations
  mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.
  C Cameron Yin, Wayne Tam, Serena M Walker, Amandeep Kaur, Madhu M Ouseph, Wei Xie, Olga K Weinberg, Peng Li, Zhuang Zuo, Mark J Routbort, Simon Chen, L Jeffrey Medeiro...> ;Haematologica. 2023 Nov 16
• 4 citations
  Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Cons...
  Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami Komrokji, Mina L Xu, Omar Abdel-Wahab, Justin Taylor, David P Steensma, Daniel ...> ;Blood Reviews. 2023 Nov 1
• 1 citations
  Diagnosis and classification of myelodysplastic syndromes.
  Robert P Hasserjian, Ulrich Germing, Luca Malcovati> ;Blood. 2023 Dec 28
• Case 29-2023: A 34-Year-Old Woman with Abdominal Distention and Acute Kidney Injury.
  Sundar Jagannath, Mark A Anderson, Andrew J Yee, Robert P Hasserjian> ;The New England Journal of Medicine. 2023 Sep 21
• Presence but not number of secondary type mutations influences outcome in de novo AML without MDS-associated or recurring cytogenetic abnormalities.
  Olga K Weinberg, Miguel D Cantu, Jeffrey Gagan, Yazan F Madanat, Daniel A Arber, Robert P Hasserjian> ;Ejhaem. 2023 Aug 1
• Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
  Michael J Hochman, Megan Othus, Robert P Hasserjian, Alex Ambinder, Andrew Brunner, Mary-Elizabeth M Percival, Christopher S Hourigan, Ronan Swords, Amy E DeZern, Elih...> ;Leukemia. 2023 Sep 1
• Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach.
  Kathryn Foucar, Adam Bagg, Carlos E Bueso-Ramos, Tracy George, Robert P Hasserjian, Eric D Hsi, Attilio Orazi, Wayne Tam, Sa A Wang, Olga K Weinberg, Daniel A Arber> ;American Journal of Clinical Pathology. 2023 Oct 3
• 10 citations
  The international consensus classification of eosinophilic disorders and systemic mastocytosis.
  Sa A Wang, Attilio Orazi, Jason Gotlib, Andreas Reiter, Alexandar Tzankov, Robert P Hasserjian, Daniel A Arber, Ayalew Tefferi> ;American Journal of Hematology. 2023 Aug 1
• Updates in Classification of Myelodysplastic Syndrome.
  Mina L Xu, Robert P Hasserjian> ;Cancer Journal. 2023 May 17
• 6 citations
  Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
  Srdan Verstovsek, Lynda Foltz, Vikas Gupta, Robert Hasserjian, Taghi Manshouri, John Mascarenhas, Ruben Mesa, Olga Pozdnyakova, Ellen Ritchie, Ivo Veletic, Katia Gamel...> ;Haematologica. 2023 Oct 1
• 1 citations
  Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Patho...
  Timothy Kirtek, Weina Chen, Dorottya Laczko, Adam Bagg, Prasad Koduru, Kathryn Foucar, Elise Venable, Meredith Nichols, Heesun J Rogers, Wayne Tam, Attilio Orazi, Eric...> ;Leukemia Research. 2023 Jul 1
• 4 citations
  Computer vision quantitation of erythrocyte shape abnormalities provides diagnostic, prognostic, and mechanistic insight.
  Brody H Foy, Jonathan A Stefely, Pavan K Bendapudi, Robert P Hasserjian, Hanny Al-Samkari, Abner Louissaint, Megan J Fitzpatrick, Bailey Hutchison, Christopher Mow, Ju...> ;Blood Advances. 2023 Aug 22
• 2 citations
  Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto-Heme Interinstitutional Collabo...
  Fitzpatrick, M., Sundaram, V., Ly, A., Abramson, J., Balassanian, R., Cheung, M., Cook, S., Falchi, L., Frank, A., Gupta, S., Hasserjian, R., Lin, O., Long, S., Menke,...> ;Cancer Cytopathology. 2023 May 1
• Pediatric myelodysplastic syndrome.
  Stephen Babcock, Katherine R Calvo, Robert P Hasserjian> ;Seminars in Diagnostic Pathology. 2023 May 1
• 2 citations
  Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements.
  Siddiqui, M., Konoplev, S., Issa, G., Kantarjian, H., Daver, N., Ravandi, F., Kadia, T., Tang, G., Wang, S., Thakral, B., Medeiros, L., Pozdnyakova, O., Pierce, S., Mo...> ;American Journal of Hematology. 2023 Apr 1
• 4 citations
  Myeloid sarcoma withmutation may be clinically and genetically distinct from AML withmutation: a study from the Bone Marrow Pathology Group.
  Maximiliano Ramia de Cap, Leo P Wu, Christian Hirt, German A Pihan, Sanjay S Patel, Wayne Tam, Carlos E Bueso-Ramos, Rashmi Kanagal-Shamanna, Philipp W Raess, Alexa Si...> ;Leukemia & Lymphoma. 2023 May 1
• 6 citations
  Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1International Workshop on MDS (iwMDS) Of t...
  Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M Brunner, Rena Buckstein, Hetty E Carraway, Jane E Churpek, Naval G Daver, ...> ;Blood Reviews. 2023 Jul 1
• 1 citations
  Diagnostic Discrepancies in Small-volume Biopsy for the Initial Diagnosis, Recurrence, and Transformation of Follicular Lymphoma: A Multi-Institutional Collaborative S...
  Volaric, A., Lin, O., Balassanian, R., Cook, S., Falchi, L., Fitzpatrick, M., Frank, A., Gupta, S., Hasserjian, R., Long, S., Ly, A., Menke, J., Mou, E., Natkunam, Y.,...> ;The American Journal of Surgical Pathology. 2023 Feb 1
• 28 citations
  Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.
  Amer M Zeidan, Uwe Platzbecker, Jan Philipp Bewersdorf, Maximilian Stahl, Lionel Adès, Uma Borate, David Bowen, Rena Buckstein, Andrew Brunner, Hetty E Carraway, Naval...> ;Blood. 2023 Apr 27
• 5 citations
  Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study.
  Yahya A Al-Ghamdi, Jonathan Lake, Adam Bagg, Beenu Thakral, Sa A Wang, Carlos Bueso-Ramos, Lucia Masarova, Srdan Verstovsek, Heesun J Rogers, Eric D Hsi, Jonathon H Gr...> ;Modern Pathology. 2023 Mar 1
• 3 citations
  Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Patholo...
  Miguel D Cantu, Rashmi Kanagal-Shamanna, Sa A Wang, Tapan Kadia, Carlos E Bueso-Ramos, Sanjay S Patel, Julia T Geyer, Wayne Tam, Yazan Madanat, Peng Li, Tracy I George...> ;JCO Precision Oncology. 2023 Jan 1
• Join now to see all

Journal Articles

• Hematopoietic Neoplasms with 9p24/JAK2 Rearrangement: A Multicenter Study  
  Guilin Tang, Daniel A Arber, Elizabeth M Margolskee, Heesun J Rogers, Robert P Hasserjian, Eric D Hsi, Sa A Wang, Wayne Tam, Adam Bagg, Olga Weinberg, Jonathan I Lake,..., Nature

Abstracts/Posters

• Bone Marrow Morphologic Findings in Patients Receiving IDH Inhibitor Therapy in Combination with Intensive Induction Chemotherapy: Challenges with Interpretation of th...
  Robert P. Hasserjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes
  Robert P. Hasserjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Diagnostic Algorithm for Lower-Risk Myelodysplastic Syndromes
  Robert Hasserjian, MD, Nature, Orlando, FL, 12/8/2019

Lectures

• Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Mye... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Clinical, Immunophenotypic and Genomic Findings  of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow P... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Surgical Pathology for the Practicing Pathologist 
  Harvard Medical School, Scottsdale, Arizona - 1/14/2012